Sansuy S.A. (BVMF:SNSY6)

Verve Therapeutics Balance Sheet

Financials in millions BRL. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	20.23	21.89	7.49	7.17	10.59	9.78
Cash & Short-Term Investments	20.23	21.89	7.49	7.17	10.59	9.78
Cash Growth	72.30%	192.45%	4.38%	-32.27%	8.29%	-24.91%
Accounts Receivable	137.76	120.91	118.61	96	101.26	94.81
Other Receivables	14.71	13.55	17.67	12.89	12.38	8.25
Receivables	152.47	134.46	136.27	108.9	113.63	103.06
Inventory	151.37	167.21	134.99	124.95	130.56	99.13
Prepaid Expenses	1.86	0.97	2.04	1.29	1.5	1.5
Other Current Assets	4.46	5.01	5.52	8.83	9.13	8.03
Total Current Assets	330.39	329.55	286.3	251.13	265.41	221.5
Property, Plant & Equipment	222.02	203.74	188.92	171.62	160.53	164.91
Long-Term Investments	2.09	2.09	2.09	1.96	1.96	1.96
Other Intangible Assets	1.25	1.29	1.28	0.71	0.64	0.66
Long-Term Accounts Receivable	1.33	1.33	12.95	12.44	12.48	0.96
Long-Term Deferred Tax Assets	2.55	2.55	3.5	3.5	3.5	3.5
Other Long-Term Assets	11.27	10.62	9.1	8.47	5.39	5.97
Total Assets	570.9	551.16	504.15	449.84	449.9	399.45
Accounts Payable	63.26	50.77	42.07	46.9	71.04	54.25
Accrued Expenses	74.41	60.27	75.83	88.16	94.2	171.85
Current Portion of Long-Term Debt	165.75	137.21	104.84	74.66	81.92	72.8
Current Portion of Leases	11.39	6.1	4.01	3.82	8.22	7.68
Current Income Taxes Payable	61.53	58.73	32.35	29.62	17.83	0.42
Other Current Liabilities	60.17	45.54	25.78	36.45	47.17	52.13
Total Current Liabilities	436.51	358.61	284.87	279.61	320.37	359.13
Long-Term Debt	65.88	64.75	50.58	53.78	44.47	51.13
Long-Term Leases	34.04	36.29	36.87	38.59	23.64	25.36
Long-Term Deferred Tax Liabilities	6.16	6.41	6.79	7.17	7.58	8.01
Other Long-Term Liabilities	2,151	2,070	2,089	1,897	1,548	1,335
Total Liabilities	2,694	2,536	2,468	2,276	1,944	1,779
Common Stock	54.63	54.63	54.63	54.63	54.63	54.63
Retained Earnings	-2,180	-2,044	-2,022	-1,887	-1,556	-1,445
Comprehensive Income & Other	20.6	21.22	22.22	23.23	24.32	25.44
Total Common Equity	-2,105	-1,968	-1,946	-1,809	-1,477	-1,365
Minority Interest	-17.72	-16.8	-18.37	-16.92	-16.28	-14.56
Shareholders' Equity	-2,123	-1,985	-1,964	-1,826	-1,494	-1,379
Total Liabilities & Equity	570.9	551.16	504.15	449.84	449.9	399.45
Total Debt	277.07	244.34	196.3	170.85	158.25	156.97
Net Cash (Debt)	-256.84	-222.45	-188.82	-163.68	-147.66	-147.19
Net Cash Per Share	-	-28.83	-24.47	-21.21	-19.14	-19.07
Filing Date Shares Outstanding	-	7.72	7.72	7.72	7.72	7.72
Total Common Shares Outstanding	-	7.72	7.72	7.72	7.72	7.72
Working Capital	-106.12	-29.06	1.43	-28.47	-54.97	-137.63
Book Value Per Share	-	-255.09	-252.14	-234.49	-191.47	-176.86
Tangible Book Value	-2,106	-1,970	-1,947	-1,810	-1,478	-1,365
Tangible Book Value Per Share	-	-255.26	-252.30	-234.58	-191.56	-176.94
Land	-	8.7	8.7	8.7	8.7	8.7
Buildings	-	70.32	66.56	67.11	69.12	68.8
Machinery	-	415.06	396.35	373.45	367.32	359.72
Construction In Progress	21.89	14.68	13.04	11.54	5.16	4.46

Source: S&P Global Market Intelligence. Standard template. Financial Sources.